Scholarlink

<p>Neuroblastoma is the most common extracranial malignancy in children, and patients who develop recurrent or metastatic disease are likely to have a much poorer survival prognosis. Herein, by applying random forest and XGBoost machine-learning techniques, we identified interferon regulatory factor (IRF) 6 as the most crucial gene associated with neuroblastoma patient survival. Low IRF6 expression was further determined to be associated with dismal survival in neuroblastoma patients. IRF6 overexpression inhibited cell proliferation in vitro and in vivo and even weakened glycolytic metabolism and increased maximal respiration in SK-N-BE2 and CHP-212 cells. Mechanistically, RNA sequencing, ChIP, and dual-luciferase reporter assays revealed that IRF6 inhibited PGM1 expression by decreasing the transcriptional activity of promoter 3 of PGM1, and PGM1 overexpression may reverse the inhibitory effects of IRF6 on cell proliferation and glycolysis. Additionally, IRF6 expression was diminished in neuroblastoma due to E3 ligase TRIM59-mediated polyubiquitination, and may reverse the promoting effect of TRIM59 overexpression on cell proliferation and glycolysis. Our work thus provides mechanistic insight into the control of glycolysis-mediated disease progression and opens new avenues for developing therapeutic strategies in neuroblastoma.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Degradation of IRF6 by TRIM59 in tumor cells triggers PGM1-mediated glycolysis to regulate cell proliferation in neuroblastoma

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年8月12日

查看全文
  • Liang Zeng,
  • Hui Xu,
  • Meng Li,
  • Liang-Jun Qin,
  • Kai Chen,
  • Feng-Hua Wang,
  • Xiaomin Li,
  • Tianyou Yang,
  • Lei Miao,
  • Hai-Yun Wang

摘要

Neuroblastoma is the most common extracranial malignancy in children, and patients who develop recurrent or metastatic disease are likely to have a much poorer survival prognosis. Herein, by applying random forest and XGBoost machine-learning techniques, we identified interferon regulatory factor (IRF) 6 as the most crucial gene associated with neuroblastoma patient survival. Low IRF6 expression was further determined to be associated with dismal survival in neuroblastoma patients. IRF6 overexpression inhibited cell proliferation in vitro and in vivo and even weakened glycolytic metabolism and increased maximal respiration in SK-N-BE2 and CHP-212 cells. Mechanistically, RNA sequencing, ChIP, and dual-luciferase reporter assays revealed that IRF6 inhibited PGM1 expression by decreasing the transcriptional activity of promoter 3 of PGM1, and PGM1 overexpression may reverse the inhibitory effects of IRF6 on cell proliferation and glycolysis. Additionally, IRF6 expression was diminished in neuroblastoma due to E3 ligase TRIM59-mediated polyubiquitination, and may reverse the promoting effect of TRIM59 overexpression on cell proliferation and glycolysis. Our work thus provides mechanistic insight into the control of glycolysis-mediated disease progression and opens new avenues for developing therapeutic strategies in neuroblastoma.